HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

In addition to men’s facial skin-care products, men’s grooming tools – including shavers, trimmers and body groomers – are outpacing the larger personal-care market, The NPD Group reports. More news in brief.

You may also be interested in...



Unilever Takes On Men’s Face Care With New Dove, AXE Launches

Unilever launches new face-care product ranges under its Dover Men+Care and AXE brands, aiming to entice men to include facial care in their daily routines.

In Brief

FDA responds to a citizen petition requesting prescription-only status for toothpastes with fluoride. NPD reports that only one-quarter of men 18+ use facial skin-care products.

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel